Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association

Ndumele, Chiadi E., Rangaswami, Janani, Chow, Sheryl L., Neeland, Ian J., Tuttle, Katherine R., Khan, Sadiya S., Coresh, Josef, Mathew, Roy O. +22 more·2023·Circulation
DOI 10.1161/cir.0000000000001184

Cited by (1,000)

Items 301–400 of 1,000

  1. Preterm Birth and Kidney Health: From the Womb to the Rest of Life
    You‐Lin Tain, Chien‐Ning Hsu · 2024 · Children
  2. The role of finerenone in the concomitant management of chronic kidney disease-type 2 diabetes and the implication for heart failure prevention and treatment
    Pam R. Taub, Stephen John Greene, Marat Fudim · 2025 · Heart Failure Reviews
  3. SELECTing Treatments for Cardiovascular Disease — Obesity in the Spotlight
    Amit Khera, Tiffany M. Powell‐Wiley · 2023 · New England Journal of Medicine
  4. EMCREG-International Multidisciplinary Consensus Panel on Management of Hyperkalemia in Chronic Kidney Disease and Heart Failure
    Natalie P. Kreitzer, Nancy M. Albert, Alpesh Amin, Craig James Beavers, Richard Clinton Becker, Gregg C. Fonarow, W. Brian Gibler, Katherine W. Kwon, Robert John Mentz, Biff F. Palmer et al. · 2025 · Cardiorenal Medicine
  5. Association between the composite dietary antioxidant index and cardiovascular-kidney-metabolic syndrome among U.S. adults: evidence from NHANES 2007–2018
    Qiuming He, Fan Hu, Wan-Hui Wei, Jie Li, Yang Yu, Heng Zhang · 2025 · Frontiers in Nutrition
  6. Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes
    Catherine G. Derington, Amara Sarwal, Guo Wei, Sydney Elizabeth Hartsell, Michael J Throolin, Ravinder Singh, McKenna R. Nevers, Chong Zhang, Niharika Katkam, Augustine Takyi et al. · 2025 · JAMA Network Open
  7. Data-driven cluster analysis identifies distinct types of cardiovascular-kidney-metabolic syndrome
    Mengge Yang, Chang Su, Xiaona Chang, Guang Wang, Jia Liu · 2025 · European Journal of Preventive Cardiology
  8. Association of SII and SIRI with incidence of cardiovascular disease in cardiovascular-kidney-metabolic syndrome: a prospective cohort study
    Chen Pengfei, Megan Lui, Lixiao Zhang, Chen Chen, Tianyu Wang, Hou Ailin, Deng Pan, Wenxi Yu, Jianpeng Du, Ming Hao Guo et al. · 2025 · Frontiers in Nutrition
  9. Cardiovascular-kidney-metabolic syndrome stages and increased risk of all-cause and cause-specific mortality in UK Biobank
    Tingting Xu, Jin Wei, Ming Xu, Huiqin Li, Silu Chen, Hongsheng Ji, Junyi Xin, Yan Gao, Mulong Du · 2025 · American Journal of Preventive Cardiology
  10. Dual clinical utility of cholesterol, high density lipoprotein, and glucose index: from advanced cardiovascular-kidney-metabolic syndrome pathogenesis to inflammatory-mediated mortality across early-transitional stages
    Benjie Li, Qixian Wang, Zhe Yu, Yujun Zhang, Jingjing Song, Chunfeng Xie, Jingyang Zhao, Xinxin Liu, Zhigang Jie, Guoyang Zhang · 2025 · Diabetology & Metabolic Syndrome
  11. Associations between cardiovascular-kidney-metabolic syndrome staging and risks of all-cause and cardiovascular mortality: a systematic review and meta-analysis
    Huimin Ding, Liqun Jiang, Yiqiu Zhao, Dongjun Lee, Buongo Chun · 2026 · American Journal of Preventive Cardiology
  12. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome: evidence from international multi-cohort studies
    Li Zhu, Yige Wu, Yunqi Yang, Lei Wang, Shihao Dou, Fangming Sun, Fan Xiang · 2026 · Cardiovascular Diabetology
  13. Management of Heart Failure With Preserved Ejection Fraction: 2026 ACC Expert Consensus Decision Pathway
    M D Kittleson, Gurusher Singh Panjrath, Katie Bates, Khadijah K Breathett, Dave L. Dixon, James L. Januzzi, Selma F. Mohammed · 2026 · Journal of the American College of Cardiology
  14. Risk Stratification and Treatment of Obesity for Primary and Secondary Prevention of Cardiovascular Disease
    John W. Ostrominski, Tiffany M. Powell‐Wiley · 2023 · Current Atherosclerosis Reports
  15. From cardiorenal syndrome to nephrocardiology: The journey of exploring the interconnection between nephrology and cardiovascular medicine
    Parta Hatamizadeh · 2024 · Trends in Cardiovascular Medicine
  16. La definición del síndrome cardiovascular-reno-metabólico (cardiovascular-kidney-metabolic syndrome) y su papel en la prevención, estatificación del riesgo y tratamiento. Una oportunidad para la Nefrología
    Aleix Cases, José Jesús Broseta, María Marqués, Secundino Cigarrán Guldris, Juan Carlos Julián Mauro, Roberto Alcázar Arroyo, Alberto Ortíz · 2024 · Nefrología
  17. Targeting lymphatic function in cardiovascular-kidney-metabolic syndrome: preclinical methods to analyze lymphatic function and therapeutic opportunities
    Joseph Wayne M. Fowler, LouJin Song, Kelly Tam, Rachel J. Roth Flach · 2024 · Frontiers in Cardiovascular Medicine
  18. Machine Learning‐Assisted Analysis of Sublingual Microcirculatory Dysfunction for Early Cardiovascular Risk Evaluation and Cardiovascular‐Kidney‐Metabolic Syndrome Stage in Patients With Type 2 Diabetes Mellitus
    Wei Liu, Wuhao Wang, Fang Sun, Nan Jiang, Liyuan Yuan, Xiaona Bu, Wentao Shu, Qiang Li, Zhiming Zhu · 2024 · Diabetes/Metabolism Research and Reviews
  19. Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes
    Brendon Lange Neuen, John W. Ostrominski, Brian Lee Claggett, Iris E. Beldhuis, Safia Chatur, Finnian R. McCausland, Sunil V. Badve, Clare Gabrielle Arnott, Hiddo J.L. Heerspink, Min Jun et al. · 2024 · Journal of the American College of Cardiology
  20. Lessons learned from the FinnDiane Study: Epidemiology and metabolic risk factors for diabetic kidney disease in type 1 diabetes
    Fanny Jansson Sigfrids, Raija Lithovius, Per‐Henrik Groop, Lena M. Thorn · 2024 · Diabetic Medicine
  21. CKM: A new approach to managing metabolic comorbidities in MASLD?
    Tianyuan Yang, Tong Bu, Bingqing Yang, Yanling Zhao, Qi Wang · 2024 · Journal of Hepatology
  22. Associations between cardiovascular-kidney-metabolic syndrome and disability in activities of daily living: a nationwide longitudinal study among the middle-aged and older adults in China
    Junfeng Jim Zhang, Huijie Huang, Zhan Lin, Jingran Dong, Xiaoyan Zhang, Jing Gao, Yin Liu, Changping Li, Zhuang Cui · 2025 · Frontiers in Public Health
  23. Associations Between Lead and Cadmium Exposure and Subclinical Cardiovascular Disease in U.S. Adults
    Lin Liu, Aimin Xu, Bernard M.Y. Cheung · 2025 · Cardiovascular Toxicology
  24. Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Case-Based Narrative Review
    Aamir Javaid, Essa H. Hariri, Bige Özkan, Katherine Lang, Sadiya S. Khan, Janani Rangaswami, Neil J. Stone, Roger Scott Blumenthal, Chiadi E. Ndumele · 2025 · American Journal of Medicine Open
  25. Association between dietary inflammatory index score and cardiovascular-kidney-metabolic syndrome: a cross-sectional study based on NHANES
    Yu Huang, Yankun Liu, Tingyi Zhang, Ziyi Guan, Ping Li · 2025 · Frontiers in Nutrition
  26. Effect of GLP-1 RA and SGLT2I on Biomarkers of Oxidative Stress in T2DM: A Systematic Review and Meta-analysis
    Huannan Wei, Lingyu Ye, Mingli Li, Shengzhu Huang, Zengnan Mo · 2025 · Journal of the Endocrine Society
  27. Association of cardiovascular-kidney-metabolic syndrome stages with kidney stone prevalence: a population-based analysis of NHANES 2007–2020
    Guo‐Liang Lu, Jinjun Tian, Feng Shi, Ding-Guo Zhang, Dawei Wang · 2025 · BMJ Open
  28. Nonlinear association of physical activity with early cardiovascular-kidney-metabolic syndrome risk: a comprehensive analysis of NHANES data from 2007 to 2018
    Haozhe Wang, Yike Zhang, Meimei Sun, Zhou Chen · 2025 · BMC Public Health
  29. Interconnected Pathways and Emerging Therapies in Chronic Kidney Disease and Heart Failure: A Comprehensive Review
    Johann K Bauersachs, Eri Toda Kato, Janani Rangaswami · 2025 · ESC Heart Failure
  30. Divergent impacts of air pollution on cardiovascular-kidney-metabolic progression: Comparative evidence from Chinese vs. British cohorts
    Yujie Shi, Jie Qiu, Jing Xue, Yan Zhang, Mintao Su, Qinfeng Zhou, Shuyu Huang, Zhisheng Liang, Yonghao Wu, Hanyang Liang et al. · 2025 · Journal of Hazardous Materials
  31. Adaptive Antioxidant Nanomedicines Inhibit Ferroptosis in Renal Tubular Epithelial Cells to Alleviate Diabetic Kidney Disease
    Zerun Liu, Ting Huang, Ying Chui Hong, Yuqi Yang, Wensheng Chen, Qingtao Zeng, Qiaohui Chen, Yongqi Yang, Xiaohong Ying, Wan Zeng et al. · 2025 · Advanced Science
  32. Established and Emerging Therapies for Cardiovascular-Kidney-Metabolic Syndrome: Harnessing the Benefits of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and Beyond
    Momina A. Allahwala, Chinmay S. Marathe, Adam J. Nelson, Peter James Psaltis, J. Marathe · 2025 · Heart Lung and Circulation
  33. Insights into the Mechanism of Action of Tirzepatide: A Narrative Review
    Rodolfo Javier Galindo, ALICE Y.Y. CHENG, Christine Longuet, Minrong Ai, Tamer Coşkun, Raleigh Malik, Jennifer C. Peleshok, Joshua A. Levine, Julia P. Dunn · 2025 · Diabetes Therapy
  34. Hepato-Renal Crosstalk in Acute and Chronic Disease: From Shared Pathways to Therapeutic Targets
    Anna Clementi, Grazia Maria Virzì, Massimiliano Sorbello, Nenzi Marzano, Paola Monciino, José Said Cabrera-Aguilar, Giovanni Giorgio Battaglia, Claudio Ronco, Monica Zanella · 2025 · Biomedicines
  35. Gut mycobiome in cardiometabolic disease progression: current evidence and future directions
    Xiaoyu Wei, Zixin Guo, Jingyang Wang, Dan Gao, Qiang Xu, Shengyu Hua · 2025 · Frontiers in Microbiology
  36. SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic Era
    Konstantinos Grigoriou, Paschalis Karakasis, Athina Nasoufidou, Panagiotis Stachteas, Aleksandra N. Klisic, Efstratios Karagiannidis, Barbara Fyntanidou, Djordje S. Popovic, Dimitrios Patoulias, Antonios P. Antoniadis et al. · 2025 · Medicina
  37. Pleiotropic Effects of SGLT2 Inhibitors: A Focus on Macrophage-Mediated Action.
    Bing Shu, Xi-Sha Chen, Zhonghao Liu, Huifang Tang, Bo Yang, Cheng-Xiao Fu · 2025 · Pharmacological Research
  38. Association between vascular aging and cardiovascular-kidney-metabolic syndrome
    Shuyi Zeng, Henghua Cui, Wang Liao, Shiyu Qiu, Zhengdong Wang, Zijia Wu, Ming Liu, Lei Chen · 2025 · Frontiers in Endocrinology
  39. Kidney function decline mediates the adverse effects of arterial stiffness on all-cause and cardiovascular disease mortality in Cardiovascular-Kidney-Metabolic syndrome population: A cohort study
    Song Liu, Qizhang Man, Shuan Wang, Yifeng Huang, Jiaye Wen, Ying Yang, Hao Xie, Lei Fan · 2025 · Diabetes Research and Clinical Practice
  40. Assessment and management of cardiovascular–kidney–liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statement
    Reinhold Hugo Kreutz, Ali Canbay, Martin Haluzı́k, Andrzej Januszewicz, Juan Manuel Mendive, Pantelis A. Sarafidis, Jörn Markus Schattenberg · 2026 · European Journal of Internal Medicine
  41. A Real-World Precision Medicine Program Including the KidneyIntelX Test Effectively Changes Management Decisions and Outcomes for Patients With Early-Stage Diabetic Kidney Disease
    Joji Erik Tokita, David Wing-Hang Lam, Aida Vega, Stephanie Y. Wang, Leonard Amoruso, T Müller, Nidhi Naik, Shivani Rathi, Sharlene Martin, Azadeh Zabetian et al. · 2024 · Journal of Primary Care & Community Health
  42. Maternal Dietary Strategies for Improving Offspring Cardiovascular–Kidney–Metabolic Health: A Scoping Review
    You‐Lin Tain, Chien‐Ning Hsu · 2024 · International Journal of Molecular Sciences
  43. Cohort profile: the prospective cohort study on the incidence of metabolic diseases and risk factors in Shunde, China (Speed-Shunde cohort)
    Heng Wan, Nanfang Yao, Jing Yang, Huang GuoQiu, Si‐Yang Liu, Xiao Wang, Lin Xu, Zhao Li, Lingling Liu, Aimin Yang et al. · 2024 · European Heart Journal - Quality of Care and Clinical Outcomes
  44. Beyond Guideline-Directed Medical Therapy
    Onyedika John Ilonze, Daniel E. Forman, Lisa Marie Lemond, JONATHAN N. MYERS, Scott L. Hummel, Amanda R. Vest, Ersilia M. DeFilippis, Eiad Habib, Sarah J. Goodlin · 2024 · JACC Heart Failure
  45. Cardiovascular-Kidney-Metabolic Syndrome Among Healthcare Workers in Chinese Tertiary Hospital
    Qingqing Zhang, Jing Zheng, Guoyu Wang, Suyun Jiang, Peng Gao, Si Sun, Xiangwei Ding, Yucheng Wu · 2024 · Risk Management and Healthcare Policy
  46. Effects of a Digital Intervention to Improve DASH and Blood Pressure Among US Adults
    Hailey Miller, Sandy Askew, Miriam B. Berger, Melissa C. Kay, Anushka Palipana, Elizabeth Trefney, Loneke T. Blackman Carr, Cherie N. Barnes, Crystal C. Tyson, Laura P. Svetkey et al. · 2024 · Hypertension
  47. Sex Differences in the Association Between Thyroid Hormone Sensitivity and Cardiovascular-Kidney-Metabolic Syndrome
    Lanxuan Jiang, Liyuan Zhou, Jia Liu, Ying Wang, Guang Wang · 2025 · The Journal of Clinical Endocrinology & Metabolism
  48. Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond
    Labib Imran Faruque, Kevin Yau, David Z.I. Cherney · 2025 · Current Opinion in Nephrology & Hypertension
  49. Correlation Between Metabolic Score for Visceral Fat and Cardiovascular-Kidney-Metabolic Syndrome: Analysis of NHANES 2011–2020
    Xi Fang, Xuemin Yin, Qianfang Liu, Jing Liu, Ying Li · 2025 · Healthcare
  50. Presepsin: An Emerging Biomarker in the Management of Cardiometabolic Disorders
    Dimitrios Kouroupis, Ioanna Zografou, Panagiotis Doukelis, Dimitrios Patoulias, Djordje S. Popovic, Paschalis Karakasis, Athina Pyrpasopoulou, Konstantinos Stavropoulos, Christodoulos E. Papadopoulos, Όλγα Γιουλεμέ et al. · 2025 · Journal of Personalized Medicine
  51. Social Determinants of Health in the Development of Cardiovascular-kidney-metabolic Syndrome
    Xinyi Cai, Tuo Li · 2025 · Reviews in Cardiovascular Medicine
  52. Incidence and Risk of Heart Failure in Patients With Coronary Heart Disease and Stroke: A Population-Based Cohort Study
    Xiaofei Liu, Peng Shen, Yi Chen, Yexiang Sun, Qi Chen, Hongbo Lin, Xun Tang, Pei Gao · 2025 · The American Journal of Cardiology
  53. Glucagon‐like peptide‐1 receptor agonists and incidence of obesity‐related cancer in adults with diabetes: A target‐trial emulation study
    Lucas A. Mavromatis, Aditya Surapaneni, Sneha Mehta, Yunwen Xu, Alex R. Chang, Vamsidhar Velcheti, Jiyoung Ahn, Jung‐Im Shin, Morgan Erika Grams · 2025 · Diabetes Obesity and Metabolism
  54. Clinical Assessment of People With Obesity: Focus on Adiposity-Related Multimorbidity
    Rosana G Bianchettin, Brent J. Gawey, Andres J Acosta, Barry A. Borlaug, Sean M. Caples, Maria L. Collazo–Clavell, Matthew M. Clark, Kyla M. Lara-Breitinger, Amir Lerman, Lilach O. Lerman et al. · 2025 · Mayo Clinic Proceedings
  55. Association of neutrophil/high-density lipoprotein cholesterol ratio with the cardiovascular-kidney-metabolic syndrome and its cardiovascular mortality
    Yaying Xu · 2025 · Frontiers in Nutrition
  56. Cardiovascular‐kidney‐metabolic health, genetic predisposition and incident risk of psoriasis
    Gang Zheng, Yixiao Zhang, Han Su, Honghao Yang, Zheng Ma, Liuxin Li, Yuqian Li, Chao Ji, Yang Xia, Yuhong Zhao · 2025 · Journal of the European Academy of Dermatology and Venereology
  57. Cardiovascular Indexes and Oxidative Balance in Advanced Cardiovascular–Kidney–Metabolic Syndrome
    Zhaoqi Yan, Xiangyi Pu, Xing Chang, Ruxiu Liu · 2025 · Obesity
  58. 2025 ACC/AHA Clinical Practice Guidelines Core Principles and Development Process: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
    Catherine M Otto, Abdul R. Abdullah, Leslie L. Davis, Victor A. Ferrari, Stephen Edward Fremes, Debabrata Mukherjee, Lauren Prestera, Boback Ziaeian · 2025 · Circulation
  59. Obesity phenotypes and atherogenic dyslipidemias
    Hun Jee Choe, Talal Almas, Ian J. Neeland, Soo Kyung Lim, Jean‐Pierre Després · 2025 · European Journal of Clinical Investigation
  60. High serum copper as a risk factor of all-cause and cause-specific mortality among US adults, NHANES 2011–2014
    Xianghui Zeng, Lanqian Zhou, Qingfeng Zeng, Hengqing Zhu, Jianping Luo · 2024 · Frontiers in Cardiovascular Medicine
  61. Patient centered care: A multidisciplinary and holistic approach
    Giovambattista Desideri, Nicola Montano, Giorgio Sesti · 2024 · European Journal of Internal Medicine
  62. Curbing the Obesity Epidemic: Should GLP-1 Receptor Agonists Be the Standard of Care for Obesity?
    Jennifer M. Kaplan, Adnin Zaman, Layla A. Abushamat · 2024 · Current Cardiology Reports
  63. Cardiovascular System, Its Functions and Disorders
    Jay P. Rabadia, Vihang S. Thite, Bhumi K. Desai, Rakesh G. Bera, Shivangi K Patel · 2024 · Springer eBooks
  64. PREVALENCE, Characteristics, and Awareness of Chronic Kidney Disease in Croatia: The EH-UH 2 Study
    Ana Jelaković, Danilo Radunović, Josipa Josipović, Tajana Željković Vrkić, Lana Gellineo, Marija Domislovic, Vladimir Prelević, Marijana Živko, Mirjana Fuček, Mihaela Marinović Glavić et al. · 2024 · Journal of Clinical Medicine
  65. The relationship between the age of onset of hypertension and chronic kidney disease: a cross-sectional study of the American population
    Lanlan Qiu, Bo Wu · 2024 · Frontiers in Cardiovascular Medicine
  66. Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 Management
    Giuseppina Gallucci, Mario Larocca, Alessandro Navazio, Fabio Maria Turazza, Alessandro Inno, Maria Laura Canale, Stefano Oliva, Giulia Besutti, Andrea Tedeschi, Daniela Aschieri et al. · 2025 · International Journal of Molecular Sciences
  67. Breastfeeding and Future Cardiovascular, Kidney, and Metabolic Health—A Narrative Review
    You‐Lin Tain, Ying-Jui Lin, Chien‐Ning Hsu · 2025 · Nutrients
  68. Advancing the translational integration of lifestyle medicine in cardiovascular–kidney–metabolic syndrome
    Zacharias Papadakis · 2025 · European Journal of Preventive Cardiology
  69. Association between depressive symptoms and mortality in patients with Cardiovascular-Kidney-Metabolic syndrome: The mediating role of inflammatory biomarkers
    Geningyue Wang, Yichuan Wu, Aomiao Chen, Lingyuan Hu, Zhuotong Wang, Xinran Xie, Qian He, Yaoming Xue, Yijie Jia, Zongji Zheng · 2025 · Journal of Affective Disorders
  70. A simple score, CKM2S2-BAG, to predict cardiovascular risk with cardiovascular-kidney-metabolic health metrics
    Yang Chun Zhao, Pan Zhou, Fangfang Fan, Yiming Hao, Wenlang Zhao, Ziyu Wang, Xuan Deng, Qiuju Deng, Yongchen Hao, Na Yang et al. · 2025 · iScience
  71. Depression and mortality in population with cardiovascular-kidney-metabolic syndrome
    Lei Li, Yali Qu, Wei‐jie Bei · 2025 · Journal of Affective Disorders
  72. Long-term air pollution exposure and cardiovascular disease risk across cardiovascular-renal-metabolic stages: a nationwide study
    Leying Zhao, Cong Zhao, Weiwei Sun, Huijuan Zheng, Yabin Gao, C. Wa, Qiong Wang, Qingqing Liu, Yaoxian Wang, Zhen Wang · 2025 · BMC Public Health
  73. Incretin-based therapy: An update focusing on the major revolution in cardiovascular-kidney-metabolic health
    Chern‐En Chiang, Kang-Ling Wang, Hao‐Min Cheng, Tze‐Fan Chao, Shih‐Hsien Sung · 2025 · Journal of the Chinese Medical Association
  74. Dietary antioxidants and mortality in early-stage CKM syndrome: insights from NHANES
    Lincheng Duan, Hong Yang, Zhuoyang Chen, Junxin Zhao, H. J. Yang, Dingjun Cai · 2025 · Nutrition & Metabolism
  75. Association between Visceral Lipid Accumulation Indicators and Advanced Cardiovascular-Kidney-Metabolic Syndrome: A Cross-Sectional Study Based on NHANES 1999–2018
    Zihan Fang, Jun Jie Yuan, Jieshan Qiu, Qi Liu, Ran He, Danna Zheng, Juan Jin, Qiang He · 2025 · Cardiorenal Medicine
  76. Association between body roundness index and advanced cardiovascular-kidney-metabolic syndrome
    Yuehui Chen, Hongxiang Tu, Min Liang, Mo Shen · 2025 · Frontiers in Nutrition
  77. Effects of ambient air pollution mixtures and household fuel use on progression to advanced cardiovascular-kidney-metabolic syndrome among middle-aged and older adults
    Shunchang Fan, Haoyue Hu, Yucheng Li, Ying Deng, Shiao Wang, Juxian Xian, Daoqi Zhu, Minyi Zhang · 2025 · Ecotoxicology and Environmental Safety
  78. Biomarkers for cardiovascular–kidney metabolic syndrome: Clinical utility in diagnosis, screening, and treatment
    Kevin Yau, David Z.I. Cherney, Ayodele Odutayo · 2025 · Diabetes Obesity and Metabolism
  79. Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology
    Sadiya S. Khan, Marwah Abdalla, Natalie Ann Bello, Ciantel Adair Blyler, Jocelyn Carter, Yvonne Y Commodore-Mensah, Keith C. Ferdinand, Heather M. Johnson, Daniel W. Jones, Amit Khera et al. · 2025 · Circulation
  80. Future of Families: Cardiovascular Health Among Young Adults Cohort Study: Rationale, Key Questions, Study Design, and Participant Characteristics
    Donald M. Lloyd‐Jones, Norrina B. Allen, James H. Stein, Hongyan Ning, Kristin Hansen, Lifang Hou, Nicole J. Katchur, Claudia E. Korcarz, Iulia Kotenko, Shantelle Little et al. · 2025 · Journal of the American Heart Association
  81. UK Biobank study of the association between circadian syndrome and cardio-kidney events or all-cause mortality
    Hong-Juan Yang, Hong Shu, Rui Chen, Qian Hou, Jiaxin Huang, Rongchong Huang, Jian‐Jun Li, Lichan Tao · 2025 · Communications Medicine
  82. Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry
    Davide Antonio Mei, Jacopo Francesco Imberti, Marco Vitolo, Giulio Francesco Romiti, Bernadette Corica, Marta Mantovani, Niccolò Bonini, Benedetta Cherubini, Francisco R. Marín, Igor Diemberger et al. · 2025 · European Journal of Internal Medicine
  83. Cardiovascular-Kidney-Metabolic Disease Burden in Children and Adults Following Heart Transplantation
    Shi Yun Huang, Jaclyn G. Tamaroff, Eric H. Farber‐Eger, Nelson Chow, Hasan Khalid Siddiqi, D. Marshall Brinkley, Jonathan Nathan Menachem, Aniket S. Rali, JoAnn M. Lindenfeld, Henry Ooi et al. · 2025 · JACC Heart Failure
  84. Vascular Aging, Cardiovascular-Kidney-Metabolic Syndrome, and Cardiovascular Risk
    Jieying Shi, Xiaomiao Ye, Shikai Yu, Yifan Zhao, Jing Xiong, Hongwei Ji, Yi Zhang · 2025 · JACC Advances
  85. Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents: Challenges of inpatient diabetes care identified by EFIM’s Diabesity Day Survey 2024
    Ann‐Kristin Porth, Anete Palma, Burcu Sallarel, Dimitrios Patoulias, Dirk Müller‐Wieland, Dror Dicker, Ieva Ruža, Il'ya Yur'evich Davidenko, Jan Škrha, Julia Brandts et al. · 2025 · European Journal of Internal Medicine
  86. Air pollution exacerbates cardiovascular-kidney-metabolic syndrome and sarcopenia comorbidity via shared genetic-epigenetic mechanisms: A multi-omics and Mendelian Randomization study
    Shuxu Wei, Zhouwu Shu, Xinyi Li, Suiqin Zhong, Ling Xiao, Ronghuai Shen, Xiaojia Lu, Lingbin He, Youti Zhang, Yan Quan et al. · 2025 · Metabolism
  87. Chronic cardiorenal syndrome: cardio-renal protective effect of SGLT2i
    Yixin Zhu, Chenxi Lv, Hanqi Yang, Qian Lü, XuChen Wang, Yueqi Zhang, Maojuan Guo, Bo Yang · 2025 · Renal Failure
  88. From kidney injury to cardiac dysfunction: the central role of oxidative stress in diabetes and CKD
    Payel Sen, Theresa Sittig, Jules Hamers, Laura d’Ambrosio, Irem Ornek, Junqing Zhang, Bachuki Shashikadze, Jan B. Stöckl, Marie Bachter, Susanne Bierschenk et al. · 2025 · Basic Research in Cardiology
  89. Light Physical Activity and All‐Cause Mortality in US Adults Across Cardiovascular‐Kidney‐Metabolic Syndrome Stages
    Joseph Sartini, Mary R. Rooney, Jennifer A. Schrack, John William McEvoy, Chiadi E. Ndumele, Scott L. Zeger, Elizabeth Selvin, Michael Fang · 2026 · Journal of the American Heart Association
  90. Multi-omics profiling reveals CKM syndrome severity as a gradient risk factor for cancer: A prospective cohort study
    Yu Huang, Yiwei Zhang, Yanjun Zhang, Ziliang Ye, Sisi Yang, Xiaoqin Gan, Yiting Wu, Yuanyuan Zhang, Xianhui Qin · 2026 · Metabolism
  91. Rising burden of MASLD and CKM syndrome in Asia: A decade of trends and future projections
    Tianqi Duo, Yun Wen, Yu Bian, Yizheng Wang, Xiaofang Zhang, Jin Ju, Yanjie Lu, Zhiguo Wang, Jinghao Wang, Baofeng Yang · 2026 · Metabolism
  92. Prognostic stratification with composite insulin resistance–inflammation biomarkers in patients with chronic kidney disease and coronary artery disease across glycemic statuses
    Zixiang Ye, Enmin Xie, Chenxi Song, R U I Zhang, Haoyu Wang, Chao Wu, Kefei Dou · 2026 · Cardiovascular Diabetology
  93. Epidemiology of cardiovascular–kidney–metabolic syndrome
    Lucas A. Mavromatis, Morgan Erika Grams · 2026 · Nature Reviews Nephrology
  94. Implementing the commitments of the World Health Assembly kidney health resolution: a key opportunity to improve health for millions
    Marcello A. Tonelli, Robert Kalyesubula, Somkanya Tungsanga, Anna Francis, John Gill, Randall Lou‐Meda, Valérie A. Luyckx, Aminu Bello · 2026 · The Lancet
  95. ROS-Activated TRPM2 Channel: Calcium Homeostasis in Cardiovascular/renal System and Speculation in Cardiorenal Syndrome
    Zihan Chen, Zaihua Cheng, Congcong Ding, Tianyu Cao, Chen Ling, Hong Wang, Junpei Li, Xiao Bo Huang · 2023 · Cardiovascular Drugs and Therapy
  96. Predicted Risk, Preclinical Heart Failure Measures, and Incident Heart Failure
    Grant, Jelani K., Zhang, Sui, Khan, Sadiya S., Ozkan, Bige, Blumer, Vanessa, Nambi, Vijay, Echouffo-Tcheugui, Justin B., Pandey, Ambarish, Blumenthal, Roger S., Ballantyne, Christie M. et al. · 2025 · JACC: Heart Failure
  97. Global Community Health Screening and Educational Intervention for Early Detection of Cardiometabolic Renal Disease
    Natalie Lana Nabaty, Tushar Menon, Garrett Trang, Aditya Vijay, Lama Chogyal, Renzo Cataldo, Navin Govind, Pankaj Jain, Priti Singh, Navaz Dolasa et al. · 2024 · Annals of Global Health
  98. Cancer mortality and geographic inequalities: a detailed descriptive and spatial analysis of social determinants across US counties, 2018–2021
    G Karadzhov, Paul S. Albert, Kevin Henry, Christian C. Abnet, Wayne Rashaan Lawrence, Meredith S. Shiels, T. Zhang, Tiffany M. Powell‐Wiley, Yingxi Chen · 2024 · Public Health
  99. Higher oxidative balance score is linearly associated with reduced prevalence of chronic kidney disease in individuals with metabolic syndrome: evidence from NHANES 1999–2018
    Linying Zhu, Xiaoyi Ruan, Jianqi Wang, Yongxing Yan, Chunyuan Tang, Yuanwen Xu · 2024 · Frontiers in Nutrition
  100. Protective Effects of the Food Supplement Flexovital in a Model of Cardiovascular-Kidney-Metabolic Syndrome in Mice
    Lucas Rannier Ribeiro Antonino Carvalho, Maria Tydén, Miho Shimari, Zhengbing Zhuge, Tomas A. Schiffer, Matheus Morais de Oliveira Monteiro, Jon O. Lundberg, Eddie Weitzberg, Daniel C. Andersson, Bengt Fellström et al. · 2024 · Nutrients